+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Glufosinate Market by Application, Crop, Formulation, End Use - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888301
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Glufosinate Market grew from USD 1.97 billion in 2024 to USD 2.17 billion in 2025. It is expected to continue growing at a CAGR of 9.95%, reaching USD 3.48 billion by 2030.

Understanding Glufosinate’s Strategic Role in Modern Agriculture

Glufosinate has emerged as a critical tool for modern weed management, offering a non-selective mode of action that complements integrated resistance strategies. Its unique enzymatic inhibition mechanism disrupts photosynthesis across a broad spectrum of weed species, making it a valuable asset for agronomists facing increasing pressure from herbicide-resistant populations.

As environmental regulations evolve and stakeholders demand more sustainable solutions, glufosinate’s environmental profile and compatibility with diverse cropping systems have elevated its strategic importance. Growers and distributors alike are reexamining their portfolios, seeking solutions that provide reliable efficacy while aligning with broader sustainability goals.

This executive summary distills the pivotal developments shaping the global glufosinate landscape. It synthesizes market shifts, regulatory milestones, and supply chain disruptions that collectively inform stakeholder decisions. In doing so, it establishes the foundation for deeper exploration of segmentation, regional variation, and competitive dynamics.

By bridging technical rigor with actionable intelligence, this overview enables decision-makers to anticipate market movements, optimize product strategies, and mitigate risks. Subsequent sections unpack the transformative forces at play, offering a roadmap for navigating the complexities of a dynamic agrochemical environment.

Disruptive Trends Reshaping the Glufosinate Marketplace

The glufosinate market has undergone profound transformation in recent years, driven by shifting agronomic practices and evolving regulatory frameworks. Integrated weed management programs now prioritize diversified modes of action, elevating glufosinate as a cornerstone tool in resistance mitigation. Coupled with the rise of traited seeds that tolerate non-selective herbicides, glufosinate applications have expanded across major row crops.

Simultaneously, regulatory agencies in key markets have tightened residue thresholds and environmental impact assessments, prompting manufacturers to innovate formulation technologies that enhance target specificity and reduce off-target risks. Advances in microencapsulation, drift reduction agents, and adjuvant packages have improved application efficiency, enabling lower active rates while maintaining control efficacy.

Digital agriculture trends have further reshaped the landscape, as precision spraying platforms integrate GPS guidance and real-time sensor data to optimize glufosinate deployment. These systems reduce waste, minimize environmental exposure, and drive adoption by demonstrating tangible cost savings and sustainability benefits.

Moreover, strategic alliances between technology providers, distributors, and research institutions have accelerated pipeline development, leading to novel formulation marks and licensing arrangements. Such collaborations are redefining channel dynamics and fostering agility in responding to regional regulatory shifts.

Together, these factors underscore a catalyzing environment in which glufosinate’s role is not merely reactive but transformative. By embracing innovation across application methods, regulatory compliance, and digital tools, stakeholders are co-creating a resilient market foundation that addresses both agronomic challenges and sustainability imperatives.

Evaluating the Ripple Effects of U.S. Tariffs on Glufosinate

The imposition of new U.S. tariffs in 2025 introduced a critical inflection point in glufosinate’s supply chain economics. With increased duties on imported technical-grade active ingredient, domestic formulators faced higher input costs that reverberated through production bottlenecks and inventory planning.

These tariff adjustments prompted many suppliers to reevaluate sourcing strategies, exploring regional partnerships and captive manufacturing options to mitigate duty impacts. In parallel, distributors engaged in forward contracting and hedging arrangements, aiming to stabilize cost structures amid currency fluctuations and tariff volatility.

End users experienced a recalibrated pricing environment, with growers in cost-sensitive segments adjusting application rates and integrating additional weed control tactics to balance operational budgets. This shift underscored the need for value-based service offerings, including agronomic support and integrated weed management advisory models.

At the same time, the tariff landscape catalyzed M&A activity as downstream players sought vertical integration to secure reliable active ingredient access and reduce exposure to import duties. Acquisitions of toll-blending facilities and joint ventures with regional producers became strategic levers for cost containment and supply resilience.

Overall, the cumulative impact of the 2025 tariff regime has been to accelerate localization, drive supply chain innovation, and reinforce the importance of diversified procurement. Stakeholders who proactively adapted to the new duty structure have positioned themselves to maintain market share and deliver consistent performance despite external trade disruptions.

Unveiling Core Dimensions of Market Segmentation

Segmentation by application reveals that foliar treatments dominate usage patterns, with growers applying glufosinate post-emergence to manage a broad spectrum of annual and perennial weeds. Pre-emergence applications provide an additional layer of soil activity, complementing the foliar approach by targeting germinating weed seedlings before they establish. Seed treatment usage, while a smaller portion of total volume, has gained traction where early vigor and residual protection are critical, particularly in no-till systems. Soil incorporation applications remain more niche, typically reserved for high-value horticultural or specialty crop scenarios.

When analyzed by crop, corn leads demand as producers leverage glufosinate-tolerant hybrids to combat complex weed carnivals in late-season applications. Soybean acreage follows closely, especially in regions where resistance to other herbicide chemistries has reduced efficacy. Wheat utilization tends to be more selective, driven by pre-plant or early tillering programs that prioritize rotational flexibility and grain quality considerations.

Formulation preferences further differentiate product offerings. Dry flowable blends attract formulators seeking stability and ease of handling, while liquid suspensions remain popular for in-field mixing and spray uniformity. Water dispersible granules have carved out a niche where dust suppression and improved storage stability align with stringent environmental regulations, particularly in regions with sensitive ecosystems.

End-use segmentation highlights the central role of commercial agriculture, where large-scale operations demand robust supply reliability, technical service offerings, and integrated digital advisory platforms. Industrial applications, such as rights-of-way and non-cropland management, emphasize rapid knockdown and minimal residual presence. In residential markets, formulations prioritize low odor, user safety, and intuitive packaging to address homeowner preferences, albeit representing a smaller fraction of overall consumption.

Diverse Regional Dynamics Driving Glufosinate Demand

Within the Americas, glufosinate adoption is driven by expansive row-crop regions in North and South America, where regulatory approvals align with genetically modified crop platforms. The United States remains a focal point for technology deployment, while Brazil’s dynamic soybean sector has emerged as a critical growth corridor, underpinned by robust distribution networks and grower education programs.

Transitioning to Europe, the Middle East & Africa, regulatory stringency and fragmented agricultural structures shape product strategies. In the European Union, the approval process emphasizes environmental risk assessments and residue management, fostering the development of low-dose formulations. Meanwhile, markets in the Middle East rely on targeted import channels and strategic stockpiling to ensure supply continuity, and African nations prioritize capacity-building initiatives to enhance weed control efficacy in staple crops.

Across Asia-Pacific, rapid expansion in rice, cotton, and horticultural acreage has fueled glufosinate uptake. Approvals in China and India have unlocked large volumes, although regulatory reviews periodically adjust maximum residue limits, influencing formulation and application protocols. Australia’s well-established agronomic advisory networks facilitate early adoption of innovative delivery systems, while Southeast Asian markets leverage contract manufacturing to meet domestic demand.

As global trade flows interconnect these regions, stakeholders must navigate diverse regulatory requirements, distribution frameworks, and agronomic priorities. Cross-regional partnerships and localized R&D investments remain key to tailoring solutions that address distinct environmental, economic, and cultural contexts.

Key Competitive Players Forging the Glufosinate Frontline

The competitive landscape for glufosinate features a core group of multinational agrochemical companies advancing product portfolios through innovation and partnerships. Leading players have invested in proprietary formulation patents, securing differentiation in application performance and environmental compatibility. Strategic alliances with biotechnology firms have resulted in co-branded traited seed solutions that reinforce barrier-to-resistance strategies.

Mid-sized specialty formulators have carved niches by emphasizing service excellence and distribution agility, supporting localized agronomic trials and digital advisory tools. These companies often leverage toll-manufacturing relationships and contract research collaborations to expand their market footprint without extensive capital outlay.

Additionally, regional players in emerging markets are gaining traction by specializing in cost-effective generic glufosinate offerings and forging distribution tie-ups with established channel partners. Their deep understanding of local regulatory pathways and grower practices enables nimble responses to shifting policy environments.

Strategic M&A activity has reshaped market shares, as global leaders acquire toll-blend facilities and regional franchises to bolster supply security and expand geographic reach. Concurrently, some companies have divested non-core assets to focus on high-value formulation platforms, optimizing their resources toward R&D and digital service models.

Overall, competitive positioning hinges on the ability to integrate technical innovation, robust supply chains, and value-added service offerings. Stakeholders with comprehensive go-to-market strategies are best positioned to capitalize on evolving grower demands and regulatory landscapes.

Strategic Imperatives for Industry Leadership

To thrive in the competitive glufosinate landscape, industry leaders should prioritize formulation innovation that enhances environmental safety and application efficiency. Investing in research collaborations focused on microencapsulation and drift reduction technologies will differentiate portfolios and meet increasingly stringent regulatory requirements.

Meanwhile, strengthening supply chain resilience through regional manufacturing partnerships and strategic inventory management can mitigate the impact of trade disruptions. Engaging in joint ventures with local producers ensures continuity of supply and reduces exposure to tariff volatility, while forward-contracting agreements provide cost predictability.

Furthermore, integrating digital agronomy platforms that deliver real-time application guidance and resistance monitoring services can enhance grower loyalty and demonstrate tangible ROI. These value-added services establish deeper customer relationships and position suppliers as trusted partners in integrated weed management.

Finally, maintaining proactive regulatory engagement and advocacy efforts will help shape favorable policy outcomes. By contributing to field research studies and environmental impact assessments, companies can support balanced risk-benefit analyses and foster timely approval processes that benefit all market participants.

Robust Methodological Framework Underpinning the Analysis

This analysis draws upon a rigorous, multi-tiered research framework encompassing both secondary and primary sources. Publicly available regulatory filings, peer-reviewed journals, and industry databases provided foundational insights into glufosinate’s technical profile, market dynamics, and competitive landscape.

Complementing these sources, in-depth interviews with agronomists, regulatory experts, and senior executives from formulators and distributors validated key trends and identified emerging challenges. Insights from on-farm trials and local extension networks added practical perspective on adoption drivers and application best practices.

Data triangulation techniques ensured consistency and reliability, cross-referencing quantitative shipment figures with qualitative feedback on grower behavior and policy developments. A dedicated advisory panel of subject-matter experts reviewed preliminary findings, offering critical feedback that refined analytical models and interpretation frameworks.

This methodological approach balances technical precision with strategic relevance, delivering actionable intelligence that supports strategic decision-making. It also establishes a transparent research trail, enabling continuous updates and iterative refinement as new data and regulatory developments arise.

Converging Insights and Future Outlook

In summary, glufosinate has solidified its role as a pivotal tool in modern weed control strategies, driven by its unique mode of action and adaptability to evolving agronomic systems. The convergence of regulatory shifts, tariff dynamics, and technological innovation has created both complexity and opportunity for stakeholders across the value chain.

By dissecting segmentation nuances, regional variations, and competitive positions, this executive summary equips decision-makers with the insights needed to navigate market uncertainties and capitalize on growth vectors. The recommended strategic imperatives-spanning formulation innovation, supply chain optimization, digital integration, and regulatory engagement-offer a roadmap for bolstering market resilience.

As the landscape continues to evolve, ongoing collaboration between industry, academia, and regulatory bodies will be essential to sustain product integrity and meet sustainability objectives. Stakeholders that embrace a proactive, data-driven approach will be best positioned to drive value and secure long-term success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Foliar
      • Post Emergence
      • Pre Emergence
    • Seed Treatment
    • Soil
  • Crop
    • Corn
    • Soybean
    • Wheat
  • Formulation
    • Dry Flowable
    • Liquid
    • Water Dispersible Granules
  • End Use
    • Commercial Agriculture
    • Industrial
    • Residential
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • BASF SE
  • Bayer AG
  • UPL Limited
  • ADAMA Ltd
  • Nufarm Limited
  • Sipcam Oxon S.p.A
  • Sumitomo Chemical Co., Ltd
  • Zhejiang Xinan Chemical Industrial Group Co., Ltd
  • Gowan Company LLC
  • Qingdao Seawin Biotech Group

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glufosinate Market, by Application
8.1. Introduction
8.2. Foliar
8.2.1. Post Emergence
8.2.2. Pre Emergence
8.3. Seed Treatment
8.4. Soil
9. Glufosinate Market, by Crop
9.1. Introduction
9.2. Corn
9.3. Soybean
9.4. Wheat
10. Glufosinate Market, by Formulation
10.1. Introduction
10.2. Dry Flowable
10.3. Liquid
10.4. Water Dispersible Granules
11. Glufosinate Market, by End Use
11.1. Introduction
11.2. Commercial Agriculture
11.3. Industrial
11.4. Residential
12. Americas Glufosinate Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Glufosinate Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Glufosinate Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. BASF SE
15.3.2. Bayer AG
15.3.3. UPL Limited
15.3.4. ADAMA Ltd
15.3.5. Nufarm Limited
15.3.6. Sipcam Oxon S.p.A
15.3.7. Sumitomo Chemical Co., Ltd
15.3.8. Zhejiang Xinan Chemical Industrial Group Co., Ltd
15.3.9. Gowan Company LLC
15.3.10. Qingdao Seawin Biotech Group
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GLUFOSINATE MARKET MULTI-CURRENCY
FIGURE 2. GLUFOSINATE MARKET MULTI-LANGUAGE
FIGURE 3. GLUFOSINATE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GLUFOSINATE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GLUFOSINATE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLUFOSINATE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GLUFOSINATE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GLUFOSINATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLUFOSINATE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLUFOSINATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLUFOSINATE MARKET SIZE, BY POST EMERGENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLUFOSINATE MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLUFOSINATE MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLUFOSINATE MARKET SIZE, BY SOIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLUFOSINATE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLUFOSINATE MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLUFOSINATE MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLUFOSINATE MARKET SIZE, BY DRY FLOWABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLUFOSINATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLUFOSINATE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLUFOSINATE MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLUFOSINATE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLUFOSINATE MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GLUFOSINATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 39. CANADA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 40. CANADA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 44. MEXICO GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 45. MEXICO GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. GERMANY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 70. GERMANY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 71. GERMANY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 73. FRANCE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. FRANCE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 75. FRANCE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 76. FRANCE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 83. ITALY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ITALY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 85. ITALY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 86. ITALY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. ITALY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SPAIN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 90. SPAIN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 91. SPAIN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 110. DENMARK GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 111. DENMARK GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 118. QATAR GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 120. QATAR GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 121. QATAR GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FINLAND GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 125. FINLAND GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 126. FINLAND GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. FINLAND GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 140. EGYPT GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 141. EGYPT GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 143. TURKEY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. TURKEY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 145. TURKEY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 146. TURKEY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. TURKEY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. NORWAY GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 155. NORWAY GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 156. NORWAY GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. NORWAY GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 158. POLAND GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. POLAND GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 160. POLAND GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 161. POLAND GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. POLAND GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC GLUFOSINATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. CHINA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 176. CHINA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 177. CHINA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. CHINA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 179. INDIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. INDIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 181. INDIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 182. INDIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 184. JAPAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. JAPAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 186. JAPAN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 187. JAPAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. THAILAND GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 206. THAILAND GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 207. THAILAND GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN GLUFOSINATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN GLUFOSINATE MARKET SIZE, BY FOLIAR, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN GLUFOSINATE MARKET SIZE, BY CROP, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN GLUFOSINATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN GLUFOSINATE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 234. GLUFOSINATE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. GLUFOSINATE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Glufosinate market report include:
  • BASF SE
  • Bayer AG
  • UPL Limited
  • ADAMA Ltd
  • Nufarm Limited
  • Sipcam Oxon S.p.A
  • Sumitomo Chemical Co., Ltd
  • Zhejiang Xinan Chemical Industrial Group Co., Ltd
  • Gowan Company LLC
  • Qingdao Seawin Biotech Group

Table Information